All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
XERIS BIOPHARMA HOLDINGS, INC. Last Reported: 5/31/2024 Stock Symbol: XERS

Business Address

1375 WEST FULTON STREET, SUITE 1300

CHICAGO , IL US 60607

Mailing Address

1375 WEST FULTON STREET, SUITE 1300

CHICAGO , IL US 60607
Phone Number: 844-445-5704 / State Incorporated: / Fiscal Year End 12 /31

Balance Sheet

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Cash and Cash Equivalents $62,690,000.00 $67,449,000.00 $46,143,000.00 $46,170,000.00 $121,966,000.00 $84,109,000.00 $95,340,000.00 $67,271,000.00 $59,492,000.00 -- -- $37,598,000.00 $37,886,000.00 -- -- $19,519,000.00
Accounts Receivable Net Current $37,414,000.00 $39,197,000.00 $45,966,000.00 $30,225,000.00 $30,830,000.00 $27,518,000.00 $25,756,000.00 $17,456,000.00 -- -- -- -- -- -- -- --
Inventory $40,878,000.00 $38,838,000.00 $38,143,000.00 $36,538,000.00 $24,735,000.00 $20,121,000.00 $17,887,000.00 $18,118,000.00 $14,241,000.00 -- -- $8,353,000.00 -- -- -- --
Prepaid Expenses and Other Current Assets -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Assets $173,280,000.00 $156,264,000.00 $158,051,000.00 $155,741,000.00 $186,818,000.00 $148,919,000.00 $161,206,000.00 $142,596,000.00 $124,367,000.00 -- -- $152,212,000.00 -- -- -- --
Property Plant and Equipement $5,783,000.00 $5,971,000.00 $6,185,000.00 $6,552,000.00 $5,516,000.00 $5,751,000.00 $6,170,000.00 $6,627,000.00 $6,682,000.00 -- -- $6,707,000.00 -- -- -- --
Intangible Assets Net $107,053,000.00 $109,764,000.00 $112,475,000.00 $115,186,000.00 $120,607,000.00 $123,318,000.00 $126,029,000.00 $131,450,000.00 -- -- -- -- -- -- -- --
Goodwill $22,859,000.00 $22,859,000.00 $22,859,000.00 $22,859,000.00 $22,859,000.00 $22,859,000.00 $22,859,000.00 $22,859,000.00 -- -- -- -- -- -- -- --
Other Assets $4,614,000.00 $4,540,000.00 $4,807,000.00 $4,808,000.00 $4,730,000.00 $2,170,000.00 $2,352,000.00 $829,000.00 $211,000.00 -- -- $232,000.00 -- -- -- --
Total Assets $336,616,000.00 $322,602,000.00 $327,784,000.00 $328,778,000.00 $344,522,000.00 $303,017,000.00 $318,616,000.00 $304,361,000.00 $131,260,000.00 -- -- $159,151,000.00 -- -- -- --
Accounts Payable $7,094,000.00 $11,565,000.00 $12,078,000.00 $11,621,000.00 $4,606,000.00 $3,916,000.00 $6,631,000.00 $8,924,000.00 $4,290,000.00 -- -- $3,117,000.00 -- -- -- --
Accrued Liabilities $22,391,000.00 $23,510,000.00 $19,073,000.00 $19,413,000.00 $36,786,000.00 $37,707,000.00 $36,945,000.00 $49,088,000.00 $22,957,000.00 -- -- $15,895,000.00 -- -- -- --
Total Current Liabilities $345,794,000.00 $329,384,000.00 $323,919,000.00 $315,137,000.00 $299,335,000.00 $247,977,000.00 $244,673,000.00 $209,130,000.00 $133,721,000.00 -- -- $125,390,000.00 -- -- -- --
Long Term Debt $229,674,000.00 $190,932,000.00 $190,423,000.00 $188,182,000.00 $187,075,000.00 $138,507,000.00 $138,068,000.00 $88,067,000.00 $87,713,000.00 -- -- $87,021,000.00 -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $-36,000.00 $-25,000.00 $-50,000.00 $-78,000.00 $-23,000.00 $-37,000.00 $-52,000.00 $-31,000.00 $-26,000.00 -- -- $6,000.00 -- -- -- --
Accumulated Deficit $-636,000,000.00 $-617,000,000.00 $-603,600,000.00 $-591,400,000.00 $-554,770,000.00 $-541,800,000.00 $-520,000,000.00 $-460,100,000.00 $-409,320,000.00 -- -- $-337,385,000.00 -- -- -- --
Total Stockholders' Equity $-9,178,000.00 $-6,782,000.00 $3,865,000.00 $13,641,000.00 $45,187,000.00 $55,040,000.00 $73,943,000.00 $95,231,000.00 $-2,461,000.00 $19,888,000.00 $44,387,000.00 $33,761,000.00 $14,336,000.00 $24,381,000.00 $27,069,000.00 $14,436,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $336,616,000.00 $322,602,000.00 $327,784,000.00 $328,778,000.00 $344,522,000.00 $303,017,000.00 $318,616,000.00 $304,361,000.00 $131,260,000.00 -- -- $159,151,000.00 -- -- -- --

Statement of Operations

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Total Revenues -- -- -- -- -- -- -- $49,590,000.00 -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- $7,840,000.00 -- -- -- $7,342,000.00 -- -- --
Research and Development $7,821,000.00 $22,341,000.00 $15,959,000.00 $10,925,000.00 $20,966,000.00 $6,043,000.00 $9,968,000.00 $25,160,000.00 $5,663,000.00 -- -- -- $3,876,000.00 -- -- --
Selling, General, and Administrative $38,380,000.00 $146,095,000.00 $108,527,000.00 $71,240,000.00 $137,745,000.00 $34,491,000.00 $32,984,000.00 $125,718,000.00 $71,539,000.00 -- -- -- $55,734,000.00 -- -- --
Total Operating Expenses -- -- -- -- -- -- -- -- $86,617,000.00 -- -- -- $71,545,000.00 -- -- --
Loss from Operations $-14,245,000.00 $-44,010,000.00 $-34,169,000.00 $-29,256,000.00 $-81,940,000.00 $-66,770,000.00 $-18,916,000.00 $-115,156,000.00 $-66,885,000.00 -- -- -- $-64,203,000.00 -- -- --
Loss Before Income Taxes -- $-63,504,000.00 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-0.14 $-0.45 $-0.36 $-0.14 $-0.70 $-0.60 $-0.19 -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 140,513,907 137,674,857 138,059,781 137,250,465 135,628,721 135,508,203 135,282,749 -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-0.14 $-0.45 $-0.09 $-0.14 $-0.70 $-0.16 $-0.44 -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 140,513,907 137,674,857 137,523,202 137,250,465 135,628,721 135,951,761 135,529,968 -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 350,000,000 350,000,000 350,000,000 350,000,000 350,000,000 350,000,000 350,000,000 350,000,000 150,000,000 -- -- 150,000,000 -- -- -- --
Common Stock Shares Outstanding 148,224,403 138,130,715 138,067,806 138,012,130 136,273,090 135,961,552 -- -- 66,497,895 -- -- 59,611,202 -- -- -- --
Common Stock Value $15,000.00 $14,000.00 $14,000.00 $14,000.00 $14,000.00 $14,000.00 $14,000.00 $13,000.00 $7,000.00 -- -- $6,000.00 -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- $0.00 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 25,000,000 25,000,000 25,000,000 25,000,000 25,000,000 25,000,000 25,000,000 25,000,000 10,000,000 -- -- 10,000,000 -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- $0.00 -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com